Bullfrog AI Holdings Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh purchased 75,000 shares of the business’s stock in a transaction on Tuesday, September 22nd. The stock was bought at an average cost of $0.60 per share, for a total transaction of $45,000.00. Following the purchase, the chief executive officer owned 2,442,446 shares of the company’s stock, valued at approximately $1,465,467.60. This represents a 3.17% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Bullfrog AI Stock Performance
NASDAQ BFRG traded up $0.11 on Tuesday, reaching $0.60. The company had a trading volume of 46,861,396 shares, compared to its average volume of 4,452,820. The firm has a market capitalization of $11.12 million, a price-to-earnings ratio of -1.30 and a beta of -2.71. The company’s fifty day moving average is $0.56 and its 200-day moving average is $0.68. Bullfrog AI Holdings Inc. has a 1-year low of $0.43 and a 1-year high of $2.04.
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last announced its earnings results on Friday, August 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.04. The firm had revenue of $0.22 million during the quarter, compared to analyst estimates of $0.21 million. On average, research analysts forecast that Bullfrog AI Holdings Inc. will post -0.37 earnings per share for the current year.
Analysts Set New Price Targets
Get Our Latest Research Report on BFRG
Institutional Trading of Bullfrog AI
An institutional investor recently bought a new stake in Bullfrog AI stock. Citadel Advisors LLC purchased a new position in Bullfrog AI Holdings Inc. (NASDAQ:BFRG – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 361,546 shares of the company’s stock, valued at approximately $257,000. Citadel Advisors LLC owned 1.95% of Bullfrog AI at the end of the most recent quarter. 0.96% of the stock is owned by hedge funds and other institutional investors.
Bullfrog AI Company Profile
BullFrog AI Holdings, Inc is a biotechnology and technology company that applies artificial intelligence and machine learning to drug development and precision medicine. The company focuses on helping pharmaceutical, biotechnology and healthcare organizations analyze complex biomedical data and identify insights that may support research and clinical decision-making.
Its primary platform, bfLEAP, is designed to process and analyze large, multidimensional datasets, including clinical, genomic and other healthcare-related information.
Featured Stories
- Five stocks we like better than Bullfrog AI
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.
